Evidence map›Paper›PMID 33476735›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2021

ImmunoPET-informed sequence for focused ultrasound-targeted mCD47 blockade controls glioma.

Natasha D Sheybani, Victoria R Breza, Soumen Paul, Katelyenn S McCauley, Stuart S Berr, G Wilson Miller, Kiel D Neumann, Richard J Price

Open access · greenAbstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Evaluation of a PET Insert for Trimodal Imaging: A Step Toward PET/MRI-Guided Focused Ultrasound.IEEE transactions on radiation and plasma medical sciences · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Targeting diffuse midline gliomas: The promise of focused ultrasound-mediated blood-brain barrier opening.Journal of controlled release : official journal of the Controlled Release Society · 2024
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Natasha D SheybaniDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, United States of America. Electronic address: nds3sa@virginia.edu.
Victoria R BrezaDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, United States of America.
Soumen PaulDepartment of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA 22908, United States of America.
Katelyenn S McCauleyDepartment of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA 22908, United States of America.
Stuart S BerrDepartment of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA 22908, United States of America.
G Wilson MillerDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, United States of America; Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA 22908, United States of America.
Kiel D NeumannDepartment of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA 22908, United States of America.
Richard J PriceDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, United States of America; Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA 22908, United States of America. Electronic address: rprice@virginia.edu.
University of Virginia · US

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Jay William FOX · 1987 to 2026
$72.1M
Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused UltrasoundR01CA197111 · NCI · UNIVERSITY OF VIRGINIA · PI BULLOCK, TIMOTHY N, ENGELHARD, VICTOR H · 2015 to 2019
$2.6M
Innovative systemic gene therapy for treating Parkinson's diseaseR01NS111102 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI PRICE, RICHARD J., SUK, JUNG SOO · 2019 to 2023
$2.6M
MRI-Guided miRNA Nanoparticle Delivery to Glioblastoma With Focused UltrasoundR01EB020147 · NIBIB · UNIVERSITY OF VIRGINIA · PI HANES, JUSTIN S., PRICE, RICHARD J. · 2015 to 2018
$2.4M
Novel imaging agents of oxidative stress in the pathophysiology of the central nervous systemR01EB028338 · NIBIB · UNIVERSITY OF VIRGINIA · PI NEUMANN, KIEL · 2020 to 2020
$2.1M
IBA Cyclone 18/9 CyclotronS10RR025087 · NCRR · UNIVERSITY OF VIRGINIA · PI BERR, STUART S. · 2008 to 2008
$2.0M
Trimodal PET/SPECT/CT Preclinical Scanner for Biomedical ResearchS10OD021672 · OD · UNIVERSITY OF VIRGINIA · PI BERR, STUART S. · 2016 to 2016
$1.2M
ImmunoPET Assessment of anti-CD47 Immunotherapy Delivery to Glioblastoma with Focused UltrasoundR21NS118278 · NINDS · UNIVERSITY OF VIRGINIA · PI PRICE, RICHARD J. · 2020 to 2020
$420k
Leveraging MR-Guided Focused Ultrasound to Potentiate Immunotherapy for GBMR21CA226607 · NCI · UNIVERSITY OF VIRGINIA · PI BULLOCK, TIMOTHY N · 2019 to 2020
$383k
Focused Ultrasound and Multifunctional Nanoparticle Vaccines as Adjuvant Strategies for Cancer ImmunotherapyK00CA234954 · NCI · STANFORD UNIVERSITY · PI SHEYBANI, NATASHA DIBA · 2020 to 2021
$183k
Focused Ultrasound and Multifunctional Nanoparticle Vaccines as Adjuvant Strategies for Cancer ImmunotherapyF99CA234954 · NCI · UNIVERSITY OF VIRGINIA · PI SHEYBANI, NATASHA DIBA · 2018 to 2019
$81k
NCI NIH HHS F99 CA234954NCI NIH HHS K00 CA234954NCI NIH HHS P30 CA044579NCI NIH HHS R01 CA197111NCI NIH HHS R21 CA226607NCRR NIH HHS S10 RR025087NIBIB NIH HHS R01 EB020147NIBIB NIH HHS R01 EB028338NIH HHS S10 OD021672NINDS NIH HHS R01 NS111102NINDS NIH HHS R21 NS118278
6 · The paper itself

Abstract

Phagocytic immunotherapies such as CD47 blockade have emerged as promising strategies for glioblastoma (GB) therapy, but the blood brain/tumor barriers (BBB/BTB) pose a persistent challenge for mCD47 delivery that can be overcome by focused ultrasound (FUS)-mediated BBB/BTB disruption. We here leverage immuno-PET imaging to determine how timing of [

Indexed as

Brain NeoplasmsGlioblastomaGliomaAnimalsBlood-Brain BarrierDrug Delivery SystemsMiceMicrobubblesBlood brain barrierCD47Focused ultrasoundGlioblastomaPET/CT

Identifiers

PMID33476735
PMCPMC7946780
OpenAlexW3123498847

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.